Dexcom Inc at JPMorgan Healthcare Conference Transcript
Good morning everyone. I'm Robbie Marcus, the Medtech analyst at JPMorgan. Thanks for joining us at the first session to kick off the 2026 JPMorgan Healthcare Conference. I'll give a warm welcome to the Dexcom CEO Jake Leach. It's his first time as President and CEO up on stage here. Jake?
All right. Good morning, everybody. Thank you, Robbie. It's an absolute privilege to be able to kick off the conference this year, particularly as my first year as President and CEO of Dexcom, and one thing I just have to say. I'm incredibly excited about the opportunity that Dexcom has to make an impact on metabolic health.
Before I jump in, a quick reminder of our safe harbor statement, and I assure you this presentation does include some forward-looking statements. Dexcom is synonymous with pioneering in the CGM industry.
You can literally map the history and the development of this category based on the innovations that Dexcom has brought to the market,
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
